主旨
免疫系统
生物
孟德尔随机化
基因敲除
表型
癌症研究
基因
细胞
间质细胞
肿瘤微环境
细胞迁移
免疫学
RNA干扰
免疫疗法
T细胞
抗体
电池类型
转录组
细胞周期
细胞生长
功能(生物学)
炎症
肿瘤进展
癌症
遗传学
作者
Xiaodong Li,Jun Yong Xiang,Zewen Chang,Qingchao Tang
摘要
ABSTRACT The tumour immune microenvironment ( TIME ) significantly influences the progression and treatment response of gastrointestinal stromal tumours ( GIST ), but the causal mechanisms and therapeutic targets remain incompletely understood. We integrated multi‐omics analyses, including Mendelian randomization analysis of 731 immune cell phenotypes to assess their causal relationship with GIST , mediation analysis to identify plasma metabolite mediators, single‐cell RNA sequencing ( scRNA ‐seq) to characterise TIME heterogeneity and bulk RNA ‐seq to screen for differentially expressed genes. Using the GIST ‐882 cell and CD8 + T cell co‐culture model, combined with functional assays such as proliferation, migration, invasion and protein uptake tracing, we validated the roles of candidate genes MYBL1 and AIF1L . Additionally, we evaluated their combined effects with PD ‐1 inhibitors. Mendelian randomization analysis identified 18 immune cell phenotypes with causal relationships to GIST (10 risk factors and 8 protective factors) and 4 mediating plasma metabolites. scRNA ‐seq revealed dynamic remodelling of the TIME . We identified genes that progressively increased or decreased from peritumoral tissues to primary tumours and metastatic tumours, and were positively correlated with PD ‐1 expression. The inhibitory effects of these genes on GIST malignant phenotypes were dependent on CD8 + T cells, and their proteins were taken up by T cells. Knockdown of MYBL1 or overexpression of AIF1L exhibited synergistic anti‐tumour effects when combined with PD ‐1 blockade. Mendelian randomization analysis identified 18 immune cell phenotypes with causal relationships to GIST (10 risk factors and 8 protective factors) and 4 mediating plasma metabolites. scRNA ‐seq revealed dynamic remodelling of the TIME . We identified genes that progressively increased or decreased from peritumoral tissues to primary tumours and metastatic tumours, and were positively correlated with PD ‐1 expression. The inhibitory effects of these genes on GIST malignant phenotypes were dependent on CD8 + T cells, and their proteins were taken up by T cells. Knockdown of MYBL1 or overexpression of AIF1L exhibited synergistic anti‐tumour effects when combined with PD ‐1 blockade. This study investigates changes in the immune microenvironment during GIST progression and identifies MYBL1 and AIF1L as key mediators regulating CD8 + T cell function and PD ‐1 response, providing new strategies for combined immunotherapy in GIST .
科研通智能强力驱动
Strongly Powered by AbleSci AI